Inventor profile of:

Gera NEUFELD

City:

Haifa

Country:

Israel

Published Applications:

22

Last publication date:

2023-08-31

Recent patent applications by NEUFELD Gera

Gera NEUFELD from Haifa, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-08-31
US20230272020A1
Chemistry; metallurgy

MODIFIED SEMAPHORIN 3A, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF

#2 | 2019-02-07
US20190040470A1
Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS AND METHODS USEFUL FOR MODULATING ANGIOGENESIS, INHIBITING METASTASIS AND TUMOR FIBROSIS, AND ASSESSING THE MALIGNANCY OF COLON CANCER TUMORS

#3 | 2018-03-01
US20180055907A1
Human necessities

COMPOSITIONS COMPRISING SEMAPHORINS FOR THE TREATMENT OF CANCER AND METHODS OF SELECTION THEREOF

#4 | 2017-06-22
US20170173111A1
Human necessities

Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases

#5 | 2016-10-27
US20160311873A1
Chemistry; metallurgy

Semaphorin 3C variants, compositions comprising said variants and methods of use thereof

#6 | 2016-09-15
US20160263182A1
Human necessities

Compositions comprising semaphorins for the treatment of cancer and methods of selection thereof

#7 | 2016-08-04
US20160222128A1
Chemistry; metallurgy

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#8 | 2015-02-12
US20150044199A1
Chemistry; metallurgy

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#9 | 2014-10-09
US20140302499A1
Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS AND METHODS USEFUL FOR MODULATING ANGIOGENESIS, INHIBITING METASTASIS AND TUMOR FIBROSIS, AND ASSESSING THE MALIGNANCY OF COLON CANCER TUMORS

#10 | 2013-12-12
US20130330349A1
Chemistry; metallurgy

HIGH AFFINITY MOLECULES CAPABLE OF BINDING A TYPE A PLEXIN RECEPTOR AND USES OF SAME

#11 | 2013-10-31
US20130287726A1
Human necessities

Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof

#12 | 2013-01-24
US20130022617A1
Chemistry; metallurgy

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#13 | 2012-08-09
US20120202206A1
Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS AND METHODS USEFUL FOR MODULATING ANGIOGENESIS, INHIBITING METASTASIS AND TUMOR FIBROSIS, AND ASSESSING THE MALIGNANCY OF COLON CANCER TUMORS

#14 | 2012-06-28
US20120165398A1
Chemistry; metallurgy

Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors

#15 | 2012-04-26
US20120101029A1
Human necessities

Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof

#16 | 2010-12-16
US20100317721A1
Chemistry; metallurgy

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#17 | 2010-09-30
US20100247516A1
Human necessities

Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof

#18 | 2010-05-13
US20100119515A1
Chemistry; metallurgy

Methods and compositions for modulating angiogenesis

#19 | 2009-11-26
US20090291891A1
Chemistry; metallurgy

VEGF variant that lacks VEGFR-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis

#20 | 2006-11-09
US20060252919A1
Chemistry; metallurgy

Vegf variant that lacks vegfr-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis

#21 | 2006-06-15
US20060127402A1
Chemistry; metallurgy

Method for assessing metastatic properties of breast cancer

#22 | 2006-04-20
US20060084622A1
Chemistry; metallurgy

Angiogenic factor and use thereof in treating cardiovascular disease

InventorID:

52436 ⎘